Clinical Trials Logo

Female Breast Cancer clinical trials

View clinical trials related to Female Breast Cancer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03836872 Terminated - Clinical trials for Female Breast Cancer

Acupuncture for Joint Symptoms in Patients With Breast Cancer

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Joint symptoms including stiffness, local pain and aches are common adverse reactions among breast cancer (BC) patients undergoing hormone treatments, while effective interventions for managing such symptoms have not been well explored so far. Acupuncture can be a promising approach to controlling joint symptoms in BC patients but current research evidence generated from several small-scale clinical studies have not been robust enough to support the use of acupuncture for cancer symptom management in routine practice. The overall aim of the research project is to examine the effectiveness of a 6-week acupuncture protocol for the management of joint symptoms in Chinese female BC patients who are currently undergoing hormone treatments following the completion of taxane-based chemotherapy. Given the lack of available data regarding the prevalence of joint symptoms in BC patients in mainland China, a large cross-sectional survey will also be performed to examine the incidence of joint symptoms among Chinese BC patients in mainland China and the impact of joint symptoms on patients' quality of life.

NCT ID: NCT01083641 Terminated - Clinical trials for Female Breast Cancer

Estrogen for Triple Negative Breast Cancer

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of Estradiol treatment for advanced breast cancer that is hormone receptor negative and Her2/neu negative. The study will also use tumor tissue from your original diagnosis or from a biopsy you may have had for your cancer to look at hormone receptors in the lab. The tissue left over from your previous surgery or a previous biopsy will be used for research tests to check whether a different estrogen receptor (estrogen receptor beta) is seen in the tumor and if that makes estrogen work better.